论文部分内容阅读
难治性非何杰金淋巴瘤(NHL)治疗较棘手,目前国外多采用包含咪托蒽醌在内的联合化疗方案,有效率50%～80%,其主要副作用为骨髓抑制,我们对一例老年、难治性、白血性 NHL 采用间歇咪托蒽醌治疗,取得一定疗效,现报道如下:患者男,72岁,1992年4月25日入院。主诉:
Refractory non-Hodgkin’s lymphoma (NHL) treatment more difficult, the current use of extra-dose combination of radiotherapy, including anthraquinone regimen, the effective rate of 50% to 80%, the main side effect of myelosuppression, a case of Senile, refractory, white blood NHL intermittent treatment with anthraquinone, achieved a certain effect, are reported as follows: The patient male, 72 years old, April 25, 1992 admission. Chief complaint: